Clinical features associated with treatment-resistant pediatric obsessive-compulsive disorder

被引:49
|
作者
Storch, Eric A. [1 ,2 ]
Merlo, Lisa J. [1 ]
Larson, Michael J. [3 ]
Marien, Wendi E. [1 ]
Geffken, Gary R. [1 ,2 ]
Jacob, Marni L. [1 ]
Goodman, Wayne K. [1 ]
Murphy, Tanya K. [1 ]
机构
[1] Univ Florida, Dept Psychiat, Gainesville, FL 32610 USA
[2] Univ Florida, Dept Pediat, Gainesville, FL 32610 USA
[3] Univ Florida, Dept Clin & Hlth Psychol, Gainesville, FL 32610 USA
关键词
D O I
10.1016/j.comppsych.2007.06.009
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Objective: The objective of the study was to identify clinical and sociodemographic characteristics that may differentiate youth with obsessive-compulsive disorder (OCD) who are resistant to treatment vs those who have a favorable response. Method: Participants included 60 outpatients, aged 7-17 years, who were determined to have previously received an adequate trial of a first-line treatment (ie, serotonin reuptake inhibitors, cognitive behavioral therapy). Patients who were treatment-resistant were compared with responders on a number of factors, including severity and nature of OCD symptoms, levels of internalizing and extemalizing symptoms, family accommodation of OCD symptoms, and functional impairment. Results: The treatment-resistant group endorsed significantly more obsessions and compulsions, greater levels of internalizing symptoms, higher parental stress related to accommodation, and greater functional impairment than treatment responders. However, relative to treatment-resistant patients, treatment responders reported higher levels of depressive symptoms, perhaps indicating that they were more distressed by their OCD symptoms, as well as greater insight into their symptoms. Conclusions: This study indicates that youth with more severe symptoms of OCD, higher related parental stress, and greater functional impairment tend to be more resistant to first-line treatments, and that perhaps they may require more intensive or family-based interventions. Treatment responders report more depressive symptoms and insight into their OCD, which may suggest a greater readiness for treatment. Further research likely would help to identify which types of treatment would be most beneficial for individual youth. (c) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:35 / 42
页数:8
相关论文
共 50 条
  • [41] Treatment-resistant Obsessive-compulsive Disorder in Young People: Assessment and Treatment Strategies
    Krebs, Georgina
    Heyman, Isobel
    CHILD AND ADOLESCENT MENTAL HEALTH, 2010, 15 (01) : 2 - 11
  • [42] EFFECTS OF ARIPIPRAZOLE AUGMENTATION IN TREATMENT-RESISTANT OBSESSIVE-COMPULSIVE DISORDER (A DOUBLE BLIND CLINICAL TRIAL)
    Sayyah, Mehdi
    Sayyah, Mohammad
    Boostani, Hatam
    Ghaffari, Seyyed Mohammad
    Hoseini, Abedin
    DEPRESSION AND ANXIETY, 2012, 29 (10) : 850 - 854
  • [43] Lamotrigine Augmentation in Treatment-Resistant Pediatric Obsessive-Compulsive Disorder with a 16 Month Follow-up
    Naguy, Ahmed
    Alamiri, Bibi
    Al-Khadhari, Souleiman
    Francis, Konstantinos
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2016, 26 (08) : 769 - 772
  • [44] Evidence-Based Treatments in Treatment-Naïve and Treatment-Resistant Pediatric Obsessive-Compulsive Disorder
    Skarphedinsson G.
    Ivarsson T.
    Current Behavioral Neuroscience Reports, 2015, 2 (3) : 127 - 136
  • [45] A pilot study of magnetic seizure therapy for treatment-resistant obsessive-compulsive disorder
    Tang, Victor M.
    Blumberger, Daniel M.
    Weissman, Cory R.
    Dimitrova, Julia
    Throop, Alanah
    McClintock, Shawn M.
    Voineskos, Daphne
    Rajji, Tarek K.
    Downar, Jonathan
    Knyahnytska, Yuliya
    Mulsant, Benoit H.
    Fitzgerald, Paul B.
    Daskalakis, Zafiris J.
    DEPRESSION AND ANXIETY, 2021, 38 (02) : 161 - 171
  • [46] Esketamine Augmentation in Treatment-Resistant Obsessive-Compulsive Disorder: A Retrospective Chart Review
    Alves-Pereira, Raiza
    Fontes, Mariana
    Cordeiro, Vivian
    Bandeira, Igor D.
    Faria-Guimaraes, Daniela
    Silva, Samantha S.
    Mello, Rodrigo P.
    Leal, Gustavo C.
    Sampaio, Aline S.
    Quarantini, Lucas C.
    CLINICAL NEUROPHARMACOLOGY, 2024, 47 (01) : 17 - 21
  • [47] A Promising Preliminary Study of Aripiprazole for Treatment-Resistant Childhood Obsessive-Compulsive Disorder
    Ercan, Eyup Sabri
    Ardic, Ulku Akyol
    Ercan, Elif
    Yuce, Deniz
    Durak, Sibel
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2015, 25 (07) : 580 - 584
  • [48] Pulse-loaded intravenous clomipramine in treatment-resistant obsessive-compulsive disorder
    Koran, LM
    Aboujaoude, E
    Ward, H
    Shapira, NA
    Sallee, FR
    Gamel, N
    Elliott, M
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2006, 26 (01) : 79 - 83
  • [49] Lamotrigine as an augmentation agent in treatment-resistant obsessive-compulsive disorder: a case report
    Uzun, Oe
    JOURNAL OF PSYCHOPHARMACOLOGY, 2010, 24 (03) : 425 - 427
  • [50] Ondansetron augmentation for the management of obsessive-compulsive disorder in a patient with treatment-resistant schizophrenia
    Yadav, Suresh
    Takacs, Anna
    Pantelis, Christos
    Thomas, Naveen
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2021, 55 (08): : 830 - 831